Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system

Background: Methylphenidate, atomoxetine, and Amphetamine are the three most commonly used medications approved by the United States Food and Drug Administration (FDA) for the treatment of attention deficit/hyperactivity disorder (ADHD). However, a comprehensive analysis of their safety profiles acr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Wei, Chen, Li, Zhou, Hui, Liu, Jinfeng, Zhang, Yue, Feng, Shiyu, Bai, Yingtao, Leng, Yanen, Chang, En, Huang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461182/
https://www.ncbi.nlm.nih.gov/pubmed/37645441
http://dx.doi.org/10.3389/fphar.2023.1208456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461182/
https://www.ncbi.nlm.nih.gov/pubmed/37645441
http://dx.doi.org/10.3389/fphar.2023.1208456

Ejemplares similares